Acticoat* (with Nanocrystalline Silver) - ¿¢Æ¼ÄÚÆ®
Á¦Ç° Ư¼º
-
Nanocrystalline Silver Antimicrobial barrier (³ª³ëÅ©¸®½ºÅ»¸° ½Ç¹ö ¾ÈƼ¸¶ÀÌÅ©·Îºñ¾ó ¹è¸®¾î)
-
Moist wound environment¸¦ À¯ÁöÇϵµ·Ï µµ¿Í ÁÜ
-
ColonizationÀÇ À§ÇèÀ» °¨¼Ò½ÃÅ´
-
150°¡Áö ÀÌ»óÀÇ º´±Õ¿¡ È¿°úÀûÀÎ barrier
-
ºü¸¥ ÀÛ¿ë
-
»ç¿ëÇϱâ Æí¸®ÇÔ
-
¹ÚÅ׸®¾ÆÀÇ Ä§Åõ¸¦ È¿°úÀûÀ¸·Î ¸·¾ÆÁÜ
-
°¨¿°¹æÁö¿¡ µµ¿òÀ» ÁÜ
-
¿À·¡ Áö¼ÓµÇ´Â È¿°ú
-
Àß ´Þ¶óºÙÁö ¾ÊÀ½
Á¦Ç° ÀåÁ¡
Nanocrystalline Silver Antimicrobial barrier
Acticoat´Â wound site¸¦ È¿°úÀûÀ¸·Î ¹æ¾îÇØ ÁÖ´Â µå·¹½Ì ÀÔ´Ï´Ù. (unique protection)
Fast acting (ºü¸¥ ÀÛ¿ë)
Acticoat´Â ºü¸£°Ô ÀÛ¿ëÇÏ´Â µå·¹½Ì ÀÔ´Ï´Ù. - ½ÇÇè½Ç Å×½ºÆ®µéÀº Acticoat°¡ ¹ÚÅ׸®¾Æ¸¦ ´Ê¾îµµ 30ºÐ¾È¿¡ ºü¸£°Ô ¹Ú¸êÇÏ´Â °ÍÀ»
ÀÔÁõÇØ ÁÖ°í ÀÖ½À´Ï´Ù. ÀÌ°ÍÀº ´Ù¸¥ ¾î¶² ½Ç¹ö Á¦Ç°º¸´Ù ºü¸¥ °á°úÀÔ´Ï´Ù.
Long lasting antimicrobial barrier (¿À·¡ Áö¼ÓµÇ´Â È¿°ú)
Acticoat´Â ±× È¿°ú°¡ 3ÀÏ ÀÌ»ó Áö¼ÓµÇ´Â ¿À·¡°¡´Â µå·¹½ÌÀÔ´Ï´Ù.
Broad spectrum
Acticoat´Â 150°¡Áö ÀÌ»óÀÇ º´±Õ¿¡ È¿°úÀûÀÎ barrier dressingÀÔ´Ï´Ù. Acticoat´Â Ç×»ýÁ¦¿¡ ³»¼ºÀÌ ÀÖ´Â
Pseudomonas, Methicillin-resistant Staphylococcus aureus (MRSA),
Vancomycin-resistant Enterococcus (VRE) µî¿¡µµ È¿°úÀû ÀÔ´Ï´Ù.
Helps prevent infection (°¨¿° ¿¹¹æ)
Acticoat´Â »óóÀÇ °¨¿°À¸·ÎºÎÅÍ º¸È£ÇØ ÁÖ°í »óóġ·á¸¦ ÃËÁø½ÃÅ°´Â ÀÛ¿ëÀ» ÇÕ´Ï´Ù.
Reduces risk of colonization
Acticoat´Â wound site°¡ colonizationµÉ À§ÇèÀ» °¨¼Ò½Ãŵ´Ï´Ù. ColonisationÀº »óóÀÇ °¨¿°À¸·Î ¹ßÀüÇÒ ¼ö
ÀÖÀ¸¸ç °¨¿°µÉ °æ¿ì »óóġ·á ±â°£ÀÌ ±æ¾îÁö°Ô µË´Ï´Ù.
°¨¿°À¸·ÎºÎÅÍ »óó¸¦ º¸È£ÇØ ÁÜÀ¸·Î½á ȯÀÚÀÇ Æí¾ÈÇÔ°ú Àç¿ø±â°£ÀÇ ´ÜÃà µîÀ¸·Î ȯÀÚÀÇ ºñ¿ëÀ» Àý°¨ÇÒ ¼ö ÀÖ½À´Ï´Ù.
Effective barrier to bacterial penetration (È¿°úÀûÀÎ ¹ÚÅ׸®¾ÆÂ÷´Ü)
Acticoat´Â wound site¸¦ º¸È£ÇÏ´Â È¿°úÀûÀÎ bacteria barrier¸¦ Á¦°øÇÕ´Ï´Ù.
Helps maintain the moist wound environment
Exudate(»ïÃâ¹°)ÀÌ ÀÖÀ¸¸é Acticoat´Â ºü¸¥wound healing¿¡ ÃÖÀûÀÎmoist wound environment¸¦ À¯ÁöÇϵµ·Ï
µµ¿ÍÁÝ´Ï´Ù.
Easy to use (Æí¸®ÇÑ »ç¿ë¹ý)
Acticoat´Â SSD Å©¸²¿¡ ºñÇØ »ç¿ëÇϱ⠽±°í Á¦°ÅÇÒ ¶§ ´ú °íÅ뽺·´½À´Ï´Ù.
Low adherent (ºñÁ¡Âø¼º)
Actocoat dressingÀÇ Á¦°Å´Â ÀüÅëÀûÀÎ ¹æ¹ý¿¡ ºñÇØ Ã³Ä¡ÀÚ³ª ȯÀÚ¿¡°Ô ´ú °íÅ뽺·´½À´Ï´Ù.
ÀûÀÀÁõ
Acticoat µå·¹½ÌÀº ºÎºÐÀûÀ¸·Î ±í°Å³ª ÀüüÀûÀ¸·Î ±íÀº È»ó, ¿åâ, Á·ºÎ±Ë¾ç, Á¤¸Æ·ù ±Ë¾ç, µµ³Ê½ÎÀÌÆ® ±×·¡ÇÁÆ® ½ÎÀÌÆ® µî¿¡ »ç¿ëÇϸé
È¿°úÀûÀÔ´Ï´Ù.
¹ÝÀûÀÀÁõ / ÁÖÀÇ»çÇ×
-
Àº¿¡ ¹Î°¨ÇÑ »ç¶÷Àº »ç¿ëÇÏÁö ¸» °Í
-
MRI °Ë»ç ÁßÀΠȯÀÚ¿¡°Ô »ç¿ëÇÏÁö ¸» °Í
-
¿Ü¿ëÀÓ
-
Àü±ØÀ̳ª Àü±â°¡ ÅëÇÏ´Â Á©°ú ´êÁö ¾Êµµ·Ï ÇÒ °Í (EEG and ECG)
-
Acticoat´Â ÁÖº¯ ÇǺθ¦ ÀϽÃÀûÀ¸·Î º¯»ö½Ãų ¼ö ÀÖÀ½
-
50µµ ÀÌ»óÀÇ ¿Âµµ¿¡ ³ëÃâµÇÁö ¾Êµµ·Ï ÇÒ °Í
-
ºû¿¡ ³ëÃâµÇÁö ¾Êµµ·Ï ÇÒ °Í
-
Á¦Ç°ÀÇ »ö»óÀÌ °í¸£Áö ¾ÊÀ» °æ¿ì »ç¿ëÇÏÁö ¸» °Í
Product Availability
Code
|
Size
|
Q'ty /Carton
|
66000791
|
10cm x 10cm
|
12°³
|
66000792
|
10cm x 20cm
|
12°³
|
66000793
|
20cm x 40cm
|
6°³
|
|
»ç¿ë¹ý
Step 1:
»óóºÎÀ§¸¦ ¼¼Ã´ÇÕ´Ï´Ù.
Step 2:
Acticoat dressingÀ» »óóũ±â¿¡ ¸Â°Ô ÀÚ¸¨´Ï´Ù.
Step 3:
»óóũ±â¿¡ ¸Â°Ô ÀÚ¸¥ Acticoat µå·¹½ÌÀ» Á¤¼öµÈ ¹°·Î ÃËÃËÈ÷ Àû½Ê´Ï´Ù.
Step 4:
ÆĶõ¸éÀÌ »óó¿¡ ´êµµ·Ï µå·¹½ÌÀ» ºÎÂøÇÕ´Ï´Ù. µå·¹½ÌÀº Ç×»ó ÃËÃËÇÏ°Ô À¯ÁöµÇ¾î¾ß ÇÕ´Ï´Ù.
Step 5:
2Â÷µå·¹½ÌÀ» ÅëÇØ ¸¶¹«¸® ÇÕ´Ï´Ù.
¸Å 3ÀÏ ¸¶´Ù ±³Ã¼Çϰųª »óȲ¿¡ ¸Â°Ô ±³Ã¼ÇÕ´Ï´Ù.
Step 6 :
ÃÖ¼Ò 3ÀÏ µ¿¾È »ç¿ë°¡´ÉÇÕ´Ï´Ù. Á¦°Å½Ã µå·¹½ÌÀÌ °ÇÁ¶ÇÒ °æ¿ì ¸ÕÀú µå·¹½ÌÀ» ÃËÃËÇÏ°Ô ÇÕ´Ï´Ù. ¹«¸®ÇÏ°Ô µå·¹½ÌÀ» Á¦°ÅÇϰųª Ä¡·áµÈ »óó¸¦
¼Õ»ó½ÃÅ°Áö ¾Êµµ·Ï ÇÕ´Ï´Ù.
ÀÓ»óÀÚ·á
Speed
-
ACTICOAT (with Nanocrystalline Silver)¢Ó kills wound pathogens faster than other
forms of silver.
-
³ª³ëÅ©¸®½ºÅ»¸° ½Ç¹ö Å×Å©·Ñ·ÎÁö·Î Á¦Á¶µÈ Acticoat´Â ´Ù¸¥ ÇüÅÂÀÇ Àº¿¡ ºñÇØ ÈξÀ »¡¸® º´±ÕµéÀ» Á×ÀÔ´Ï´Ù.
Performance
-
ACTICOAT (with Nanocrystalline Silver)¢Ó assists faster healing by protecting
the wound from bacterial contamination and helping to maintain a moist wound
environment1
-
³ª³ëÅ©¸®½ºÅ»¸° ½Ç¹ö Å×Å©³î·ÎÁö¿¡ ÀÇÇØ Á¦Á¶µÈ Acticoat´Â »óó°¡ ¹ÚÅ׸®¾Æ¿¡ contamination µÇ´Â °ÍÀ» ¸·°í ¸ðÀ̽ºÆ® ¿îµå ȯ°æÀ»
À¯ÁöÇϵµ·Ï µµ¿ÍÁÝ´Ï´Ù.
Protection
-
ACTICOAT (with Nanocrystalline Silver)¢Ó protects the wound from bacterial
contamination and helps prevent infection from a broad spectrum of wound
pathogens?1,2,3
-
³ª³ëÅ©¸®½ºÅ»¸° ½Ç¹ö Å×Å©³î·ÎÁö·Î Á¦Á¶µÈ Acticoat´Â »óó°¡ ¹ÚÅ׸®¾Æ¿¡ contamination µÇ´Â °ÍÀ» ¹æÁöÇÏ°í ±¤¹üÀ§ÇÑ (¾à 150¿©
°¡Áö) º´±Õ¿¡ °¨¿°µÇ´Â °ÍÀ» ¹æÁöÇϵµ·Ï ÇØÁÜ
Reference 1. Wright et al. American Journal of Infection Control 1998; 26(6):
572-577
Reference 2. Wright et al. American Journal of Infection Control 1999; 27(4):
344-350
pathogen type
|
sample species
|
gram-negative bacteria
|
P. aeruginosa, P. stutzeri, E. cloacae,
E. aerogenes, E. coli, K. pneumoniae,
B. cepacia
|
gram-positive bacteria
|
S. aureus, S. epidermidis, E. faecium,
E. faecalis
|
Antibiotic-resistant bacteria |
Methicillin-resistant S. aureus (MRSA),
Vancomycin-resistant E. faecium and
E. faecalis (VRE), multi-drug resistant
B. cepacia
|
fungal organisms |
C. glabrata, C. albicans, C. tropicalis,
S. cerevisiae
|
|
|